BACH2 is a major risk locus for Addison's disease, according to a study published in the Journal of Internal Medicine.
In the United Kingdom, rates of the disease were highest for those born in December, while in Poland, rates were highest for those born in January.
The first-ever guideline from Endocrine Society on Addison's disease details specifics of diagnostic tests and glucocorticoid therapy.
Adrenal insufficiency appears to impact patients differently and influences their beliefs about hydrocortisone replacement.
Addison disease patients may not benefit from continuous subcutaneous hydrocortisone infusion.
Endocrinology Advisor Articles
- Clinicians May Be Overtreating Older Patients With Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Prediabetes a Useful Indicator for Cardiovascular and Renal Risks